FMBTD
AXSM icon

First Midwest Bank Trust Division’s Axsome Therapeutics AXSM Stock Holding History

First Midwest Bank Trust Division’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$4.35M Buy
+115,028
New +$4.23M 0.56% 38

Other funds holding AXSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

First Midwest Bank Trust Division's AXSM Position: Q4 2021 in Review

First Midwest Bank Trust Division opened a new position in Axsome Therapeutics (AXSM) in Q4 2021: 115,028 shares worth $4.35M. The stake represents 0.56% of the portfolio and ranks #38 among its holdings.

167 funds tracked by Wall St. Rank hold AXSM as of Q4 2021.

  • First Midwest Bank Trust Division held 115,028 shares of Axsome Therapeutics worth $4.35M as of Q4 2021.
  • Axsome Therapeutics was a new First Midwest Bank Trust Division position in Q4 2021.
  • Axsome Therapeutics made up 0.56% of First Midwest Bank Trust Division's portfolio in Q4 2021, its #38 holding.
  • 167 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2021.

Based on First Midwest Bank Trust Division's 13F filing for Q4 2021, filed 18 Jan 2022.